[The U.S. 2026 Healthcare Cliff: When The Business Model Is The Real Risk](https://wbbsec.com/opinions-and-features/the-u-s-2026-healthcare-cliff-when-the-business-model-is-the-real-risk/)
[The U.S. 2026 Healthcare Cliff: When The Business Model Is The Real Risk](https://wbbsec.com/opinions-and-features/the-u-s-2026-healthcare-cliff-when-the-business-model-is-the-real-risk/)

News

The U.S. 2026 Healthcare Cliff: When the Business Model Is the Real Risk

Posted in:Opinions & Features

New insight from WBB Securities President Dr. Steve Brozak in Forbes.
In “The U.S. 2026 Healthcare Cliff: When the Business Model Is the Real Risk,” Steve explores how the potential expiration of enhanced ACA subsidies could expose longstanding structural weaknesses in the U.S. healthcare system, from reimbursement incentives to rising costs and access challenges.
The article highlights why this moment matters for healthcare companies, investors, policymakers, and patients alike.

Read More about The U.S. 2026 Healthcare Cliff: When the Business Model Is the Real Risk
By:

Diagnosing Medicaid Cuts To Hospitals In The One, Big, Beautiful Bill – Published in Forbes

Posted in:Opinions & Features

In his latest Forbes article, WBB Securities President Dr. Steve Brozak examines the hidden dangers behind recent Medicaid funding cuts buried within a sweeping federal spending bill. Titled “Diagnosing Medicaid Cuts To Hospitals In The One Big Beautiful Bill”

Read More about Diagnosing Medicaid Cuts To Hospitals In The One, Big, Beautiful Bill – Published in Forbes
By:

WBB Securities acted as the sole placement agent for a $9 million Series A funding round for FELIQS

Posted in:Press Releases

WBB Securities today announced it had acted as the sole placement agent for a $9 million Series A funding round for FELIQS, a biotechnology company developing first-in-class small molecule therapeutics for rare pediatric retinal diseases. 

Read More about WBB Securities acted as the sole placement agent for a $9 million Series A funding round for FELIQS
By:

WBB Securities invites you to attend the upcoming Demy-Colton Virtual Salon titled: “Seven Years After FDA Approval: What Have We Learned About Cell and Gene Therapies?”.

Posted in:Press Releases

WBB Securities invites you to attend the upcoming Demy-Colton Virtual Salon titled:
“Seven Years After FDA Approval: What Have We Learned About Cell and Gene Therapies?”.

Read More about WBB Securities invites you to attend the upcoming Demy-Colton Virtual Salon titled: “Seven Years After FDA Approval: What Have We Learned About Cell and Gene Therapies?”.
By:
Load More